Clinical Trial Update: Induced Angiogenesis by Genic Therapy in Advanced Ischemic Cardiomyopathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating induced angiogenesis via genic therapy for advanced ischemic cardiomyopathy; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Cardiomyopathy

Drugs mentioned

• Genic Therapy for Induced Angiogenesis

Snippet

Sponsor: Instituto de Cardiologia do Rio Grande do Sul | Conditions: Ischemic Cardiopathy | Phase 2 | Status: UNKNOWN